Fred Rein is partner in Goodwin’s IP Litigation Group and a member of the firm’s Israel and Tech/Life Sciences Practices. He is a U.S. registered patent attorney with over 25 years of experience at the intersection of technology and law.




For more than a quarter of a century, Mr. Rein has focused on patent litigation, strategic counseling and patent-related due diligence. Many of his litigation matters have concerned  well-known pharmaceutical products such as CARDIZEM, CLARITIN, DITROPAN XL, ELOXATIN, LIPITOR, LOVAZA, MONOPRIL, REBETOL, PRISTIQ, SELDANE, WELLBUTRIN XL and ZANTAC. See, e.g., Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc., 217 F.Supp.3d 782 (D. Del. 2016) (Trial victory relating to a generic version of NASONEX based on Mr. Rein’s examination of the parties’ expert witnesses including Merck’s expert who used one of the world’s most powerful X-ray diffraction facilities, the synchrotron at Argonne National Laboratory, in an unsuccessful attempt to prove infringement).

Professional Experience

Prior to joining Goodwin in 2001 to help start its IP law practice in New York, Mr. Rein was a partner at a well-known IP law firm. Earlier in his career, he clerked at the U.S. District Court for the Central District of California (located in Los Angeles). He previously served on the Patents Committee of the Association of the Bar of the City of New York and is currently involved in the Israel Practice committee of the American Intellectual Property Law Association (AIPLA) and the Tech Division committee of UJA. Mr. Rein has also partnered with The Legal Aid Society with respect to litigation relating to Title VII of the Civil Rights Act of 1964.


Mr. Rein has repeatedly been named a “Life Sciences Star” by LMG Life Sciences. He has served as an editor of the Journal of Generic Medicines for over a decade and has spoken about intellectual property law at various conferences, including those organized by the International Generic and Biosimilar Medicines Association, the Food and Drug Law Institute, the Intellectual Property Institute of Canada and the Hebrew University Faculty of Law. While in law school, Mr. Rein was Managing Editor of the Boston College Environmental Affairs Law Review. In graduate school, he was a recipient of a New York University Fellowship and a Conoco Scholarship.

In The News

In den Nachrichten






J.D., 1989
Boston College Law School
M.A., 1986
New York University
B.S., Biology, 1984
Rensselaer Polytechnic Institute


1989 to 1990 U.S. District Court for the Central District of California, Honorable Ralph J. Geffen



New York
U.S. Patent and Trademark Office (USPTO)


U.S. Court of Appeals for the Federal Circuit
U.S. Court of Appeals for the Second Circuit
U.S. District Court for the Eastern District of New York
U.S. District Court for the Southern District of New York
Get In Touch
In Kontakt kommen
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers
Suche Andere Rechtsanwälte